Thrombotic Microangiopathies

Also known as: Thrombotic Microangiopathy / Thrombotic microangiopathy (disorder) / Thrombotic microangiopathy NOS / Other thrombotic microangiopathy / Purpura, Thrombotic Thrombocytopenic / Moschcowitz syndrome / Thrombocytopenic purpura, thrombotic / Purpura thrombopenic thrombotic / Purpura thrombopaenic thrombotic / Thrombotic thrombocytopenic purpura / Thrombotic thrombocytopenic purpura (disorder)

DrugDrug NameDrug Description
DB01257EculizumabA recombinant humanized monoclonal antibody used to reduce the risk of hemolysis in paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).
DB11580RavulizumabA monoclonal antibody used to treat paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and myasthenia gravis.
DrugDrug NamePhaseStatusCount
DB04932Defibrotide2Completed1
DB04932Defibrotide2Not Yet Recruiting1
DB01257Eculizumab2Completed1
DB05202Egaptivon pegol2Terminated1
DB16418Narsoplimab2Completed1
DB16418Narsoplimab2Recruiting1
DB06151Acetylcysteine3Completed1
DB01257Eculizumab3Not Yet Recruiting1
DB00441Gemcitabine3Not Yet Recruiting1
DB16418Narsoplimab3Unknown Status1
DB14991Nomacopan3Recruiting1
DB11580Ravulizumab3Active Not Recruiting1
DB11580Ravulizumab3Recruiting2
DB11580Ravulizumab3Terminated1
DB01257EculizumabNot AvailableCompleted1
DB16418NarsoplimabNot AvailableAvailable1